First in Human: 7739 Clinical Trials, Page 33 of 774

Hide Studies Not Open or Pending

326

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Condition(s):Head and Neck Squamous Cell Carcinoma; Melanoma Excluding Uveal Melanoma; Non-small Cell Lung Cancer, Squamous or Non-squamous; Urothelial Carcinoma; Renal Cell Carcinoma, Clear Cell; Castration-resistant Prostate Cancer; Ovarian Cancer, Epithelial; TNBC – Triple-Negative Breast Cancer; Colorectal CancerLast Updated:November 14, 2023Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.